Skip to main content
. 2021 Jul 28;13(7):392–402. doi: 10.14740/jocmr4542

Table 1. Demographic Data and Baseline Characteristics.

Demographic data and baseline characteristics Switzerland, N (%) Other countries, N (%) Total, N (%) P-value
Number of patients 94 (100.00) 7,514 (100.00) 7,608 (100.00)
Age at registration (years) < 0.0001
  N 94 7,514 7,608
  Mean 69.91 65.30 65.36
  SD 10.07 9.33 9.35
  Min 44.00 40.00 40.00
  Median 71.00 66.00 66.00
  Max 92.00 95.00 95.00
  Nmiss 0 0 0
Age at registration (categorical) < 0.0001
  < 65 years 23 (24.47) 3,426 (45.59) 3,449 (45.33)
  ≥ 65 years 71 (75.53) 4,088 (54.41) 4,159 (54.67)
Gender 0.03
  Male 54 (57.45) 5,121 (68.15) 5,175 (68.02)
  Female 40 (42.55) 2,393 (31.85) 2,433 (31.98)
Duration between initial diagnosis of COPD and baseline visit (years) 0.03
  N 94 7,514 7,608
  Mean 5.63 4.91 4.92
  SD 5.41 5.87 5.86
  Min 0.00 0.00 0.00
  Median 4.00 3.00 3.00
  Max 26.00 72.00 72.00
  Nmiss 0 0 0
COPD degree of severity (spirometric) 0.00
  1 5 (5.32) 152 (2.02) 157 (2.06)
  2 57 (60.64) 3,420 (45.52) 3,477 (45.70)
  3 29 (30.85) 3,100 (41.26) 3,129 (41.13)
  4 2 (2.13) 752 (10.01) 754 (9.91)
  No previous findings 1 (1.06) 90 (1.20) 91 (1.20)
mMRC questionnaire 0.41
  Grade 0 5 (5.32) 246 (3.27) 251 (3.30)
  Grade 1 23 (24.47) 1,762 (23.45) 1,785 (23.46)
  Grade 2 43 (45.74) 3,167 (42.15) 3,210 (42.19)
  Grade 3 21 (22.34) 1,903 (25.33) 1,924 (25.29)
  Grade 4 2 (2.13) 436 (5.80) 438 (5.76)
GOLD Group 0.91
  A 20 (21.28) 1,479 (19.68) 1,499 (19.70)
  B 39 (41.49) 3,214 (42.77) 3,253 (42.76)
  C 8 (8.51) 529 (7.04) 537 (7.06)
  D 27 (28.72) 2,292 (30.50) 2,319 (30.48)
Patients with concomitant diseases < 0.0001
  No 4 (4.26) 2,126 (28.29) 2,130 (28.00)
  Yes 90 (95.74) 5,388 (71.71) 5,478 (72.00)
Patients with concomitant medication (except respiratory therapeutics) < 0.0001
  No 16 (17.02) 3,008 (40.03) 3,024 (39.75)
  Yes 78 (82.98) 4,506 (59.97) 4,584 (60.25)
Smoking status 0.60
  Smoker 37 (39.36) 3,025 (40.26) 3,062 (40.25)
  Ex-smoker 47 (50.00) 3,454 (45.97) 3,501 (46.02)
  Non-smoker 10 (10.64) 1,035 (13.77) 1,045 (13.74)
Pack-years 0.01
  N 84 6479 6563
  Mean 37.93 35.37 35.41
  SD 14.19 20.03 19.97
  Min 5.00 0.00 0.00
  Median 40.00 32.00 32.00
  Max 70.00 292.00 292.00
  Nmiss 10 1,035 1,045
Patients with exacerbations in the last 12 months prior to study 0.83
  Yes 60 (63.83) 4,874 (64.87) 4,934 (64.85)
  No 34 (36.17) 2,640 (35.13) 2,674 (35.15)
Number of exacerbations in the last 12 months prior to study 0.55
  N 94 7,514 7,608
  Mean 1.17 1.08 1.08
  SD 1.18 1.10 1.10
  Min 0.00 0.00 0.00
  Median 1.00 1.00 1.00
  Max 5.00 12.00 12.00
  Nmiss 0 0 0

COPD: chronic obstructive pulmonary disease; SD: standard deviation; mMRC: modified Medical Research Council questionnaire; Nmiss: number missings.